These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7221879)

  • 1. The effect of monooctanoin on retained common duct stones.
    Gadacz TR
    Surgery; 1981 May; 89(5):527-31. PubMed ID: 7221879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of retained biliary stones with monooctanoin: report of 16 patients.
    Tritapepe R; Di Padova C; Pozzoli M; Rovagnati P; Montorsi W
    Am J Gastroenterol; 1984 Sep; 79(9):710-4. PubMed ID: 6475901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application.
    Thistle JL; Carlson GL; Hofmann AF; LaRusso NF; MacCarty RL; Flynn GL; Higuchi WI; Babayan VK
    Gastroenterology; 1980 May; 78(5 Pt 1):1016-22. PubMed ID: 7380174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of retained common bile duct stones with monooctanoin infusion.
    Braghetto I; Csendes A; Velasco N
    Ital J Surg Sci; 1985; 15(4):355-60. PubMed ID: 3830956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of retained common duct stones with intraductal infusion of monooctanoin (author's transl)].
    Velasco N; Csendes A
    Rev Med Chil; 1980 Nov; 108(11):1021-3. PubMed ID: 7244447
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of retained common bile duct stones: a prospective controlled study comparing monooctanoin and heparin.
    Velasco N; Braghetto I; Csendes A
    World J Surg; 1983 Mar; 7(2):266-70. PubMed ID: 6868639
    [No Abstract]   [Full Text] [Related]  

  • 7. Monooctanoin infusion and stone removal through the transparenchymal tract: use in 17 patients.
    Haskin PH; Teplick SK; Sammon JK; Gambescia RA; Zitomer N; Pavlides CA
    AJR Am J Roentgenol; 1987 Jan; 148(1):185-8. PubMed ID: 3491511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monooctanoin perfusion for in vivo dissolution of biliary stones. A series of 11 patients.
    Teplick SK; Haskin PH
    Radiology; 1984 Nov; 153(2):379-83. PubMed ID: 6484170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monooctanoin use for gallstone dissolution.
    Abate MA; Moore TL
    Drug Intell Clin Pharm; 1985 Oct; 19(10):708-13. PubMed ID: 3902430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of retained common bile duct stones in patients with T-tube in situ: role of endoscopic sphincterotomy.
    Tandon RK; Nijhawan S; Arora A
    Am J Gastroenterol; 1990 Sep; 85(9):1126-31. PubMed ID: 2389725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution of retained common bile duct stones using monooctanoin. A case report documented with cholangiography.
    Cassat JD; Shannon GJ
    S D J Med; 1982 Mar; 35(3):7-10. PubMed ID: 6953591
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection of patients for dissolution of retained common duct stones with mono-octanoin.
    Sharp KW; Gadacz TR
    Ann Surg; 1982 Aug; 196(2):137-9. PubMed ID: 7092363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution of gallstones: comparison of monooctanoin, sodium dehydrocholate, heparin, and saline.
    Teplick SK; Pavlides CA; Goodman LR; Babayan VK
    AJR Am J Roentgenol; 1982 Feb; 138(2):271-3. PubMed ID: 6976729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monooctanoin dissolution of retained biliary stones in high risk patients.
    Steinhagen RM; Pertsemlidis D
    Am J Gastroenterol; 1983 Nov; 78(11):756-60. PubMed ID: 6637969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones.
    Minuk GY; Hoofnagle JH; Jones EA
    J Clin Gastroenterol; 1982 Apr; 4(2):133-5. PubMed ID: 7086106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotizing choledochomalacia after use of monooctanoin to dissolve bile-duct stones.
    Crabtree TS; Dykstra R; Kelly J; Preshaw RM
    Can J Surg; 1982 Nov; 25(6):644-6. PubMed ID: 7139418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of garlic oil as a contact dissolution agent for gallstones: comparison with monooctanoin.
    Nijhawan S; Agarwal V; Sharma D; Rai RR
    Trop Gastroenterol; 2000; 21(4):177-9. PubMed ID: 11194578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal infusion of mono-octanoin: experience in 24 patients with retained common-duct stones.
    Jarrett LN; Balfour TW; Bell GD; Knapp DR; Rose DH
    Lancet; 1981 Jan; 1(8211):68-70. PubMed ID: 6109120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of retained choledocholithiasis with monooctanoin].
    Becerra E; Schultz H; Monsalves M; Muñoz MA; Calvo C; Silva D; Vera D; Israel G; Jara P
    Rev Med Chil; 1983 Feb; 111(2):149-52. PubMed ID: 6648090
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissolution of cholesterol ductal stones in the biliary tree with medium-chain glycerides.
    Uribe M; Uscanga L; Farca S; Sanjurjo JL; LaGarriga J; Ortíz JH
    Dig Dis Sci; 1981 Jul; 26(7):636-40. PubMed ID: 7249900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.